Aetiology, pathogenesis, and pathology of cervical neoplasia

Journal of Clinical Pathology

Volumn 51, Issue 2, 1998, Pages 96-103

  Arends, M J ^a   Buckley, C H ^b   Wells, M ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Cervical neoplasia; Human papillomavirus

Indexed keywords

CADHERIN; PROTEIN P53;

CANCER SCREENING; CONDYLOMA ACUMINATUM; ECTOPIC TISSUE; FEMALE; HLA TYPING; HUMAN; PAPILLOMA VIRUS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS ONCOGENE; VIRUS TYPING;

EID: 0031888717     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.51.2.96     Document Type: Review

References (77)

1. Munoz N, Bosch X, Kaldor JM. Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence. Br J Cancer 1987;57:1-5.
2. Munoz, N, Bosch FX. Current views on the epidemiology of HPV and cervical cancer. In: Lacey C, ed. Papillomavirus reviews: current research on papillomaviruses. Leeds: Leeds University Press, 1996:227-37.
3. Vonka V, Kanka J, Roth Z. Herpes simplex type II and cervical neoplasia. Adv Cancer Res 1987;48:149-91.
4. Van Ranst M, Tachezy R, Burk RD. Human papillomaviruses: a never ending story? In: Lacey C. Papillomavirus reviews: current reserch on papillomaviruses. Leeds: Leeds University Press, 1996:1-19.
5. Arends MJ, Wyllie AH, Bird CC. Papillomaviruses and human cancer. Hum Pathol 1990;21:686-98.
6. Arends MJ, Donaldson YK, Duvall E, et al HPV in full thickness cervical biopsies: high prevalence in CIN 2 and CIN 3 detected by a sensitive PCR method. J Pathol 1991; 165:301-9.
7. Arends MJ, Donaldson YK, Duvall E, et al. HPV 18 associates with more advanced cervical neoplasia than HPV 16. Hum Pathol 1993;24:432-7.
8. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
9. Sehiffman MH, Bauer HM, Lorincz AT, et al. Comparison of southern blot hybridisation and polymerase chain reaction methods for the detection of human papillomavirus DNA. J Clin Microbiol 1991;29:573-7.
10. Cuzick J, Terry G, Ho L, et al. Type-specific human papillomavirus DNA in abnormal smears as a predictor of high grade cervical intraepithelial neoplasia. Br J Cancer 1994;69:167-71.
11. deVilliers E-M, Wagner D, Schneider A, et al. Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet 1987;ii:703-5.
12. Stanley M. Genital papillomaviruses, polymerase chain reaction and cervical cancer. Genitourin Med 1990;66:415-17.
13. Lorincz AT, Reid R, Jenson AB, et al. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynaecol 1992;79:328-37.
14. Van den Brule AJC, Snijders PJF, Meijer CJLM, et al. PCR based detection of genital HPV genotypes: an update and future perspectives. In: Lacey C, ed. Papillomavirus reviews: current research on papillomavirus. Leeds: Leeds University Press, 1996:181-8.
15. Guerrero E, Shah KV. Polymerase chain reaction in HPV diagnosis. In: Lacey C, ed. Papillomavirus reviews: current research on papillomavirus. Leeds: Leeds University Press, 1996:175-80.
16. Kurman RJ, Schiffman MH, Lancaster WD, et al. Analysis of individual papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression. Am J Obstet Gynecol 1988;159:293-6.
17. International Agency for Research on Cancer (IARC). Human papillomaviruses. Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Vol. 64 Lyon: IARC, 1995.
18. Crook T, Vousden KH. HPV oncoprotein function. In: Lacey C, ed. Papillomavirus reviews: current research on papillomaviruses. Leeds: Leeds University Press, 1996:55-60.
19. Schwarz, E, Freese UK, Gissmann L, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985;314:111-14.
20. Choo K-B, Pan C-C, Han S-H. Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology 1987;161:259-61.
21. Thierry E HPV proteins in the control of HPV transcription. In: Lacey C, ed. Papillomavirus reviews: current research on papillomaviruses. Leeds: Leeds University Press, 1996: 21-9.
22. Shirasawa H, Tomita Y, Sekiya S, et al. Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas. J Gen Virol 1987;68:583-91.
23. Smotkin D, Wettstein FO. The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein. J Virol 1987;61:1686-9.
24. Woodworth CD, Bowden PE, Doniger J, et al. Characterization of normal human exocervical epithelial cells immortalized in vitro by papillomavirus types 16 and 18 DNA. Cancer Res 1988;48:4620-8.
25. Woodworth CD, Doniger J, DiPaolo JA. Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma. J Virol 1989;63:159-64.
26. McDougall JK. HPV immortalisation and transformation. In: Lacey C, ed. Papillomavirus reviews: current research on papillomaviruses. Leeds: Leeds University Press, 1996:47-53.
27. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 1994;186:131-56.
28. Storey A, Pim D, Murray A, et al. Comparison of the in vitro transforming activities of human papillomavirus types. EMBO J 1988;7:1815-20.
29. Durst M, Gallahan D, Jay G, et al. Glucocorticoid enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene. Virology 1989;173:767-71.
30. Arends MJ, McGregor AH, Wyllie AH. Apoptosis is inversely related to necrosis and determines net growth in tumours bearing constitutively expressed myc, ras and HPV oncogenes. Am J Pathol 1994;144:1045-57.
31. Phelps WC, Yee CL, Munger K, et al. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 1988;53:539-47.
32. Munger K, Werness BA, Dyson N, et al. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 1989;8: 4099-105.
33. Munger K, Yee CL, Phelps WC, et al. Biochemical and biological differences between E7 oncoproteins of the high and low risk human papillomavirus types are determined by amino terminal sequences. J Virol 1991;65:3943-8.
34. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 proteins with p53. Science 1990;248:76-9.
35. Scheffner M, Munger K, Byrne JC, et al. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 1991;88:5523-7.
36. Lane SA, Wells M. Human papillomavirus, p53 and cervical neoplasia. J Pathol 1994;172:299-300.
37. Jeffers MD, Richmond J, Farquharson M, et al. p53 immunoreactiviry in cervical intraepithelial neoplasia and non-neoplastic cervical squamous epithelium. J Clin Pathol 1994;47:1073-76.
38. Busby-Earle RMC, Steel CM, Williams ARW, et al. p53 mutations in cervical carcinogenesis: low frequency and lack of correlation with human papillomavirus status. Br J Cancer 1994;69:732-7.
39. White AF, Livanos EM, Tlsty T. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Develop 1994;8:666-77.
40. Arends MJ, Wyllie AH, Bird CC. HPV 18 is associated with less apoptosis in fibroblast tumours than HPV 16. Br J Cancer 1995;72:646-9.
41. Banks L, Matlashewski G. Biochemical and biological activities of the HPV E5 proteins. In: Lacey C, ed. Papillomavirus reviews: current research on papillomaviruses. Leeds: Leeds University Press, 1996:39-45.
42. Garrenstroom KN, Melkert P, Walboomers JMM, et al. Human papillomavirus DNA and genotypes: prognostic factors for progression of cervical intraepithelial neoplasia. Int J Gynecol Cancer 1994;4:73-8.
43. Herrington CS, Evans MF, Hallam NF, et al. Human papillomavirus status in the prediction of high grade cervical intraepithelial neoplasia in patients with persistent low-grade cytological abnormalities. Br J Cancer 1995;71:206-9.
44. Cox JT. HPV DNA testing: clinical boon or boondogle? Lancet 1995;346:717-18.
45. Londesborough P, Ho L, Terry G, et al. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 1996;69:364-8.
46. Brandsma JL. Animal models for human papillomavirus vaccine development. In: Lacey C, ed. Papillomavirus reviews: current research on papillomaviruses. Leeds: Leeds University Press, 1996:69-78.
47. Khare S, Tang S-C, Pater MM, et al. Cofactors with HPV in infection and oncogenesis. In: Lacey C, ed. Papillomavirus review: current research on papillomaviruses. Leeds: Leeds University Press, 1996:239-46.
48. Benton EC, Arends MJ. Human papillomavirus in the immunosuppressed. In: Lacey C, ed. Papillomavirus reviews: current research on papillomaviruses. Leeds: Leeds University Press, 1996:271-9.
49. Arends MJ, Benton EC, McLaren KM, et al. Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy. Br J Cancer 1997;75:722-8.
50. Luesley D, Blomfield P, Dunn J, et al. Cigarette smoking and histological outcome in women with mildly dyskaryotic cervical smears. Br J Obstet Gynaecol 1994;101:49-52.
51. Sasson IM, Haley NJ, Hoffmann D, et al. Cigarette smoking and neoplasia of the uterine cervix: smoke constituents in cervical mucus. N Engl J Med 1985;312:315.
52. Ali S, Astley SB, Sheldon TA, et al. Detection and measurement of DNA adducts in the cervix of smokers and non-smokers. Int J Gynecol Cancer 1994;4:188-93.
53. Warwick AP, Redman CWE, Jones PW, et al. Progression of cervical intraepithelial neoplasia to cervical cancer: interactions of cytochrome P 450 CYP2D6 EM and glutathione S-transferase GSTM1 null genotypes and cigarette smoking. Br J Cancer 1994;70:704-8.
54. Hughes DE, Rebello G, Al-Nafussi A. Integrin expression in squamous neoplasia of the cervix. J Pathol 1994;173:97-104.
55. Vessey CJ, Wilding J, Folarin N, et al. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J Pathol 1995;176: 151-9.
56. Anderson MC, Brown C, Buckley CH, et al. Current views on cervical intraepithelial neoplasia. J Clin Pathol 1991;44: 969-78.
57. Anderson MC. Premalignant and malignant squamous lesions of the cervix. In: Fox H, ed. Haines and Taylor: obstetrical and gynaecological pathology. Edinburgh: Churchill Livingstone, 1995:273-322.
58. Buckley CH. Tumors of the cervix uteri. In: Fletcher CDM, ed. Diagnostic histopathology of tumors. Edinburgh: Churchill Livingstone, 1995b:478-94.
59. Lowe DG, Buckley CH, Fox H. Advances in gynaecological pathology. In: Anthony PP, MacSween RNM, Lowe DG, eds. Recent advances in histopathology. Edinburgh: Churchill Livingstone, 1997:113-37.
60. National Cancer Institute Workshop. The 1988 Bethesda system for reporting cervical vaginal cytologic diagnoses. Hum Pathol 1988;21:704-8.
61. Richart RM. Natural history of cervical intraepithelial neoplasia. Clin Obstet Gynecol 1968;10:748-84.
62. Östör AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12: 186-92.
63. McIndoe WA, McLean MR. Jones RW, et al. The invasive potential of carcinoma in situ of the cervix. Obstet Gynecol 1984;64:451-8.
64. Al-Nafussi Al, Hughes DE. Histological features of CIN 3 and their value in predicting invasive microinvasive squamous carcinoma. J Clin Pathol 1994;47:799-804.
65. Shepherd JH. Revised FIGO staging for gynaecological cancer. Br J Obstet Gynecol 1989;96:889-92.
66. Shepherd JH. Staging announcement. FIGO staging of gynaecologic cancers: cervical and vulval [erratum Int J Gynecol Cancer 1995;5:465]. Int J Gynecol Cancer 1995;5: 319.
67. Östör AG, Rome RM. Micro invasive squamous cell carcinoma of the cervix: a clinico-pathologic study of 200 cases with long-term follow-up. Int J Gynecol Cancer 1994; 4:257-4.
68. Burghardt E, Östor A, Fox H. The new FIGO definition of cervical cancer stage IA: a critique. Gynecol Oncol 1997;65: 1-5.
69. Arends MJ. How do cancer cells die? Apoptosis and its role in neoplastic progression. In: Leake R, Gore M, Ward RH, eds. The biology of gynaecological cancer. London: RCOG Press, 1995:73-91.
70. Buckley CH. Oncogene expression in gynaecological cancer. In: Leake R, Gore M, Ward RH, eds. The biology of gynaecological cancer. RCOG Press, 1995a:21-33.
71. Griffin NR, Wells M. Pre-malignant and malignant disease (adenocarcinoma) of the endocervix. In: Fox H, ed. Haines & Taylor: obstetrical and gynaecological pathlogy. 4th ed. Edinburgh: Churchill Livingstone, 1995:323-43.
72. Östör AG, Pagano R, Davoren RA, et al. Adenocarcinoma in situ of the cervix. Int J Gynecol Pathol 1984;3:179-90.
73. NHS CSP. The reporting of histological specimens in the context of the cervical screening programme. Sheffield: NHS CSP Publications. [In press.]
74. Casper GR, Östor AG, Quinn MA. A clinicopathologic study of glandular dysplasia of the cervix. Gynecol Oncol 1997;64:166-70.
75. Duggan MA, Benoit JL, McGregor SE, et al. Adenocarcinoma in situ of the endocervix: human papillomavirus determination by dot blot hybridization and polymerase chain reaction amplification. Int J Gynecol Pathol 1994;13: 143-9.
76. Ursin G, Peters RK, Henderson BE, et al. Oral contraceptive use and adenocarcinoma of the cervix. Lancet 1994;344:1390-4.
77. Kasper HG, Dinh TV, Doherty MG, et al. Clinical implications of tumor volume measurement in stage 1 adenocarcinoma of the cervix. Obstet Gynecol 1993;81:296-300.